Posted in | News | Green Energy | Wind Power

Côte-de-Beaupré RCM and Boralex Commission Community Wind Farm Project

Côte-de-Beaupré Regional County Municipality ("RCM") and Boralex Inc. ("Boralex" or the "Corporation") are pleased to announce commercial commissioning of the Côte-de-Beaupré community wind farm project. This 23.5 MW capacity project is located on the private lands of the Seigneurie de Beaupré, in the Côte-de-Beaupré region, Québec.

Ms. Parise Cormier, Côte-de-Beaupré RCM Warden, "thanked its partner Boralex for its exceptional collaboration in the completion of this community wind farm, which will create a regional development fund to implement a sustainable development plan for the Côte‑de‑Beaupré communities." In addition, Ms. Cormier thanked the Séminaire de Québec, which authorized the wind farm's construction on its private lands.

Patrick Lemaire, Boralex President and CEO, pointed out that "the experience gained from the construction of the previous Seigneurie de Beaupré development phases made optimal completion of the community wind farm project possible, in addition to its commissioning two weeks ahead of schedule."

Covered by a 20-year contract with Hydro-Québec, project construction resulted in direct impacts of over $2 million for the Côte-de-Beaupré region. As a project partner,
Côte-de-Beaupré RCM will also benefit from annual average net revenues of $800,000.

Note that the 23.5 MW Côte-de-Beaupré wind farm, whose ownership is shared by Côte‑de‑Beaupré RCM (49%) and Boralex (51%), is part of Seigneurie de Beaupré Wind Farms, with total contracted capacity of 365 MW — making it one of Canada's largest wind power projects to date. The 272 MW Phase I, commissioned in late 2013, and 68 MW Phase II, commissioned in late 2014, are Boralex and Gaz Métro | Valener consortium projects.

For more information, visit the Seigneurie de Beaupré Wind Farms site at: www.seigneuriedebeaupre.com.

Source: http://www.boralex.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.